BLOOD-GLUCOSE LIMITS IN THE DIAGNOSIS OF IMPAIRED GLUCOSE-TOLERANCE DURING PREGNANCY - RELATION TO MORBIDITY

被引:25
作者
NORD, E [1 ]
HANSON, U [1 ]
PERSSON, B [1 ]
机构
[1] ST GORANS UNIV HOSP,KAROLINSKA INST,DIV PEDIAT,STOCKHOLM,SWEDEN
关键词
GESTATIONAL DIABETES MELLITUS; NEONATAL MORBIDITY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY;
D O I
10.3109/00016349509013467
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective. To evaluate the accuracy of diagnosing gestational diabetes mellitus (GDM) by a 2-h blood glucose value greater than or equal to 9.0 mmol/1 in the 75 g oral glucose tolerance test (OGTT). The maternal and neonatal outcome in women with a 2-h blood glucose value just below this limit, 8.0-8.9 mmol/1, is analyzed. The outcome is compared to a randomly selected control group. Design. A comparative study. Subjects. There were 223 women in the group with a 2-h value of 8.0 to 8.9 mmol/1 in the OGTT This group was compared to a randomly selected control group of 391 women. Main outcome measures. Fetal outcome: perinatal mortality, birth weight, respiratory disturbances, symptomatic hypoglycemia, polycythemia, hyperbilirubinemia and traumatic deliveries. Maternal age, body mass index (BMI), pregnancy-induced hypertension (PIH) or preeclampsia and route of delivery. Results. The women in the group with a 2-h glucose value of 8.0-8.9 mmol/1 were, compared to the control group, significantly older, heavier, had a higher BMI, gave birth to heavier children and a significantly increased number of large-for-date infants, while there were no differences in neonatal mortality, morbidity or birth trauma. Conclusions. This study shows that using the 75 g 2-h OGTT with a B-glucose limit of greater than or equal to 9.0 mmol/1 instead of greater than or equal to 8.0 mmol/1 to diagnose GDM during pregnancy has no major adverse effects concerning maternal and neonatal outcome in the borderline interval of 8.0 to 8.9 mmol/1.
引用
收藏
页码:589 / 593
页数:5
相关论文
共 16 条
[1]  
WHO Expert Committee on Diabetes Mellitus, (1980)
[2]  
Diabetes Mellitus, Report of a WHO Study Group, (1985)
[3]  
Lind T., A prospective multicentre study to determine the influence of pregnancy upon the 75 g oral glucose tolerance test (OGTT), Carbohydrate metabolism in pregnancy and the newborn. IV, pp. 209-226, (1988)
[4]  
Lind T., Andersson J., Does random blood glucose sampling outdate testing for glucosuria in the detection of diabetes during pregnancy?, Br Med J, 289, pp. 1569-1571, (1984)
[5]  
Nasrat A.A., Johnstone F.D., Hasam SAM, Is random plasma glucose an efficient screening test for abnormal glucose tolerance in pregnancy?, Br J Obstet Gynaecol, 95, pp. 855-860, (1988)
[6]  
Javaid H.R., Saadia R., Shamim M., Amin R., Ata K.M., Experience with screening for abnormal glucose tolerance in pregnancy: Maternal and perinatal outcome, Asia Oceania J Obstet Gynaecol, 18, pp. 99-105, (1992)
[7]  
Persson B., Stangenberg M., Hanson U., Nordlander E., Gestational diabetes mellitus (GDM), Comparative evaluation of two treatment regimens, diet versus insulin and diet. Diabetes, 34, pp. 101-105, (1985)
[8]  
Karlberg P., Priolisi A., Landstrom T., Selstam U., Clinical analyses of causes of death with emphasis on perinatal mortality, Fundamentals of mortality risks during the perinatal period and infancy, Monographs in Pediatrics, 9, (1977)
[9]  
O'Sullivan J.B., Gellis S.S., Tenney B.O., Gestational blood glucose levels in normal and potential diabetic women related to the birth weight of their infants, Diabetes, 15, pp. 466-470, (1966)
[10]  
Willman S.P., Leveno K.J., Guzick D.S., Williams M.L., Whalley P.J., Glucose threshold for macrosomia in pregnancy complicated by diabetes, Am J Obstet Gynecol, 154, pp. 470-475, (1986)